Clinical efficacy of new antifungal agents
- 9 August 2006
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 9 (5) , 483-488
- https://doi.org/10.1016/j.mib.2006.08.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisJournal of Infection, 2006
- Micafungin: A New EchinocandinClinical Infectious Diseases, 2006
- Amphotericin B and Caspofungin Resistance in Candida glabrata Isolates Recovered from a Critically Ill PatientClinical Infectious Diseases, 2006
- Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve EndocarditisAntimicrobial Agents and Chemotherapy, 2005
- Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal TherapyClinical Infectious Diseases, 2004
- Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2004
- Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 2004
- Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and CandidemiaAntimicrobial Agents and Chemotherapy, 2004
- Caspofungin Resistance inCandida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida EsophagitisAntimicrobial Agents and Chemotherapy, 2004
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002